Tracer has developed a proprietary platform for tumor-informed circulating-tumor DNA detection using digital PCR.

Labcorp will acquire portions of the lab's clinical and women's health testing businesses, while MAWD will continue to provide anatomic and other pathology services.

Last week, readers were most interested in a story about Gates Foundation Awards to Detact Diagnostics to further develop a POC system and assays to detect infectious diseases.